Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

This publication has 15 references indexed in Scilit:

• From hepatitis C virus infection to B-cell lymphoma
  Annals of Oncology, 2017
• International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement
  Autoimmunity Reviews, 2017
• Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
  Blood, 2016
• Direct‐acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN‐free treatment and future perspectives
  Liver International, 2016
• Hepatitis C
  The Lancet, 2015
• Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study
  American Journal of Hematology, 2014
• Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi
  Annals of Oncology, 2014
• Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience
  Journal of Clinical Oncology, 2005
• Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?
  Blood, 2005
• Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection
  New England Journal of Medicine, 2002